HANSON GREGORY P

Insider CIK 1186120 · MBVX Chief Financial Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise deriv	2018-04-02	2018-04-03	7,021	—	$0	0	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise	2018-04-02	2018-04-03	7,021	—	$0	116,735	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	F Tax w/h	2018-04-02	2018-04-03	2,428	—	$0	114,307	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2018-02-21	2018-02-23	195,000	—	$0	195,000	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2018-01-16	2018-01-18	41,873	$0.92	$38.5K	320,013	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2018-01-12	2018-01-16	11,232	$0.96	$10.8K	361,886	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2018-01-11	2018-01-16	38,697	$0.98	$37.9K	373,118	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2018-01-10	2018-01-16	66,550	$0.96	$63.9K	411,815	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise deriv	2018-01-08	2018-01-16	449,159	—	$0	0	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise	2018-01-08	2018-01-16	449,159	—	$0	478,365	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2017-10-02	2017-10-04	340,420	—	$0	340,420	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2017-09-15	2017-09-18	108,739	—	$0	108,739	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale deriv	2017-05-19	2017-08-02	3,119	—	$0	0	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale deriv	2017-05-19	2017-08-02	3,119	—	$0	0	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy	2017-05-19	2017-08-02	4,842	—	$0	38,334	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy	2017-05-19	2017-08-02	4,286	$1.75	$7.5K	33,492	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-12	2017-04-14	3,885	$2.00	$7.8K	29,206	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-11	2017-04-11	200	$2.00	$400	33,091	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-10	2017-04-11	400	$2.00	$800	33,291	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-07	2017-04-11	450	$2.01	$904	33,691	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-06	2017-04-06	867	$2.15	$1.9K	34,141	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-05	2017-04-06	1,800	$2.15	$3.9K	35,008	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	S Sale	2017-04-04	2017-04-06	1,000	$2.25	$2.3K	36,808	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise deriv	2017-04-02	2017-04-04	21,064	—	$0	21,063	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise	2017-04-02	2017-04-04	21,064	—	$0	37,808	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2017-02-06	2017-02-08	75,000	$2.99	$224.3K	75,000	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2017-01-01	2017-01-03	26,400	$3.38	$89.2K	26,400	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2016-08-29	2016-08-30	26,400	$5.00	$132.0K	26,400	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy deriv	2016-08-17	2016-08-19	3,119	—	$0	3,119	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy deriv	2016-08-17	2016-08-19	3,119	—	$0	3,119	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy	2016-08-17	2016-08-19	3,119	—	$0	16,744	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise deriv	2016-04-04	2016-04-05	155,867	—	$0	311,733	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	F Tax w/h	2016-04-04	2016-04-05	58,044	—	$0	100,823	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	M Exercise	2016-04-04	2016-04-05	155,867	—	$0	158,867	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2016-02-16	2016-02-18	20,000	$0.49	$9.8K	20,000	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2015-04-02	2015-04-03	467,600	$2.30	$1.08M	467,600	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	A Award deriv	2015-04-02	2015-04-03	467,600	—	$0	467,600	SEC↗
MBVX MABVAX THERAPEUTICS HOLDIN	P Buy	2014-12-16	2014-12-17	3,000	$2.50	$7.5K	3,000	SEC↗